Legal Opinion
Amarin Pharma Inc. v. Hikma Pharmaceuticals USA Inc.
District Court, D. Nevada
Decided April 30, 2021No. 2:16-cv-02525Unknown
1Opinion
2 UNITED STATES DISTRICT COURT 3 DISTRICT OF NEVADA 4 * * * 5 AMARIN PHARMA, INC., et al., Case No. 2:16-cv-02525-MMD-NJK 6 Plaintiffs, ORDER v. 7 HIKMA PHARMACEUTICALS USA INC., 8 et al., 9 Defendants. 10 11 I. SUMMARY 12 This was a consolidated patent infringement case brought under the Hatch- 13 Waxman Act where Plaintiffs Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland 14 Limited (collectively, “Amarin”) sought to prevent Defendants West-Ward 15 Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc. (collectively, 16 “Hikma”), and Dr. Reddy’s Laboratories, Inc.…
2Cases cited20 opinions
- Smith v. MarshCourt of Appeals for the Ninth Circuit · 1999
- Headwaters Inc., an Oregon Nonprofit Corporation Forest Conservation Council v. U.S. Forest ServiceCourt of Appeals for the Ninth Circuit · 2005
- United States v. Alisal Water Corp.Court of Appeals for the Ninth Circuit · 2004
- Donnelly v. GlickmanCourt of Appeals for the Ninth Circuit · 1998
- Wilderness Society v. United States Forest ServiceCourt of Appeals for the Ninth Circuit · 2011
15 more not listed; retrieve them via the Exa API.